Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Payables (2023 - 2025)

Historic Payables for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $21.0 million.

  • Nuvation Bio's Payables rose 82.67% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 82.67%. This contributed to the annual value of $12.6 million for FY2024, which is 47179.72% up from last year.
  • As of Q3 2025, Nuvation Bio's Payables stood at $21.0 million, which was up 82.67% from $28.0 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Payables registered a high of $28.0 million during Q2 2025, and its lowest value of $2.2 million during Q4 2023.
  • For the 3-year period, Nuvation Bio's Payables averaged around $11.6 million, with its median value being $12.6 million (2024).
  • Examining YoY changes over the last 5 years, Nuvation Bio's Payables showed a top increase of 77678.04% in 2024 and a maximum decrease of 1728.35% in 2024.
  • Quarter analysis of 3 years shows Nuvation Bio's Payables stood at $2.2 million in 2023, then surged by 471.8% to $12.6 million in 2024, then soared by 66.08% to $21.0 million in 2025.
  • Its Payables stands at $21.0 million for Q3 2025, versus $28.0 million for Q2 2025 and $16.2 million for Q1 2025.